HSP90B1 and cancer: Since GRP94 is responsible for the maturation and trafficking of proteins involved in cell signaling and motility, the treatment of GRP94-selective inhibitor 30 has shown potent anti-cancer activity in aggressive and metastatic cancers [209] (Table 7).